NEW YORK, Dec. 13, 2017 /PRNewswire-HISPANIC PR WIRE/ – You may be affected by a class action lawsuit against Medicis Pharmaceutical Corp., and Impax Laboratories, ("Defendants"). The lawsuit claims that Defendants unlawfully delayed the availability of allegedly less-expensive generic versions of Solodyn and that Defendants' conduct caused certain consumers and third-party payors (discussed below) to pay too much for Solodyn in these states and territories. Defendants deny any wrongdoing.